Jushi (JUSHF) Stock Price, News & Analysis

Company Overview

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of cannabis for medical and adult-use markets. The company offers flower, extracts, concentrates, edibles, oil, pre-rolls, tinctures, capsules, softgels, cannabis-infused gummies and ultra-premium chocolate, and topicals products, as well as vaporization devices and cartridges under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. It is also involved in the bulk wholesale of refined cannabinoids and terpenes. In addition, the company operates medical cannabis dispensaries under the BEYOND/HELLO, Nature's Remedy, and NuLeaf brands. It markets its products to local dispensaries and large multi-state operators. The company is headquartered in Boca Raton, Florida.

Key Stats

• Today's Range: $0.30 to $0.32
• 50-Day Range: $0.27 to $0.44
• 52-Week Range: $0.22 to $0.69
• Volume: 3,504 shs
• Average Volume: 181,568 shs
• Market Capitalization: $62.04 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Reduce

Jushi Stock Analysis - MarketRank™

Jushi scored higher than 20% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Jushi.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Jushi are expected to grow in the coming year, from ($0.23) to ($0.17) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Jushi is -1.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Jushi is -1.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.34% of the float of Jushi has been sold short.

Short Interest Ratio / Days to Cover

Jushi has a short interest ratio ("days to cover") of 4.6.

Change versus previous month

Short interest in Jushi has recently decreased by 9.23%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Jushi does not currently pay a dividend.

Dividend Growth

Jushi does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.34% of the float of Jushi has been sold short.

Short Interest Ratio / Days to Cover

Jushi has a short interest ratio ("days to cover") of 4.6.

Change versus previous month

Short interest in Jushi has recently decreased by 9.23%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 1.6 / 5
• News Sentiment: N/A

News Sentiment

Jushi has a news sentiment score of 0.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Jushi this week, compared to 1 article on an average week.

MarketBeat Follows

Only 1 people have added Jushi to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Jushi insiders have not sold or bought any company stock.

Percentage Held by Insiders

22.48% of the stock of Jushi is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

Only 21.68% of the stock of Jushi is held by institutions.

JUSHF Stock Analysis - Frequently Asked Questions

How have JUSHF shares performed this year?

Jushi's stock was trading at $0.3110 at the start of the year. Since then, JUSHF stock has increased by 1.4% and is now trading at $0.3155.
View the best growth stocks for 2025 here.

How were Jushi's earnings last quarter?

Jushi Holdings Inc. (OTCMKTS:JUSHF) released its quarterly earnings data on Thursday, May, 8th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.06) by $0.03. The company earned $63.85 million during the quarter, compared to the consensus estimate of $66.23 million.

How do I buy shares of Jushi?

Shares of JUSHF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Last Earnings: 5/08/2025
• Today: 7/01/2025
• Next Earnings (Estimated): 8/06/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: OTCMKTS:JUSHF
• CIK: 1909747
• Web: www.jushico.com
• Phone: 561-617-9100
• Fax: N/A
• Employees: 1,234
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.24)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$48.78 million
• Net Margins: -18.54%
• Pretax Margin: -6.48%
• Return on Equity: N/A
• Return on Assets: -10.71%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.13
• Quick Ratio: 0.57

Sales & Book Value

• Annual Sales: $257.52 million
• Price / Sales: 0.24
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.26) per share
• Price / Book: -1.21

Miscellaneous

• Outstanding Shares: 196,632,000
• Free Float: 154,042,000
• Market Cap: $62.04 million
• Optionable: Not Optionable
• Beta: -1.18